Table 3.

Number and percentage of individuals by demographic characteristics by follow-up attributes

Total population, n (%)Individuals with 10 years of follow-up, n (%)Individuals with consecutive follow-up, n (%)Individuals who were active in 2023 or 2024, n (%)
Total population 10 412 2626 8228 8481 
Age, y     
<12 2 662 (26) 323 (12) 2 296 (28) 2 400 (28) 
12 to <18 1 731 (17) 711 (27) 1 391 (17) 1 520 (18) 
18 to <30 2 767 (27) 748 (28) 2 100 (25) 2 150 (25) 
≥30 3 252 (31) 844 (32) 2 441 (30) 2 411 (28) 
Sex     
Female 5 418 (52) 1 416 (54) 4 289 (52) 4 416 (52) 
Male 4 994 (48) 1 210 (46) 3 939 (48) 4 065 (48) 
Type of site     
Pediatric 4 446 (42) 1 325 (50) 3 611 (44) 3 827 (45) 
Adult 2 703 (26) 282 (11) 2 033 (25) 2 105 (25) 
Life span 3 263 (31) 1 019 (39) 2 551 (31) 2 549 (30) 
Sickle cell type     
HbSS 6 782 (65) 1 764 (67) 5 473 (67) 5 530 (65) 
HbS/β0 251 (2) 68 (3) 203 (2) 212 (2) 
HbSC 2 602 (25) 625 (24) 1 954 (24) 2 105 (25) 
HbS β+ 669 (6) 146 (5) 506 (6) 550 (6) 
Other type 108 (1) 23 (1) 92 (1) 84 (1) 
Total population, n (%)Individuals with 10 years of follow-up, n (%)Individuals with consecutive follow-up, n (%)Individuals who were active in 2023 or 2024, n (%)
Total population 10 412 2626 8228 8481 
Age, y     
<12 2 662 (26) 323 (12) 2 296 (28) 2 400 (28) 
12 to <18 1 731 (17) 711 (27) 1 391 (17) 1 520 (18) 
18 to <30 2 767 (27) 748 (28) 2 100 (25) 2 150 (25) 
≥30 3 252 (31) 844 (32) 2 441 (30) 2 411 (28) 
Sex     
Female 5 418 (52) 1 416 (54) 4 289 (52) 4 416 (52) 
Male 4 994 (48) 1 210 (46) 3 939 (48) 4 065 (48) 
Type of site     
Pediatric 4 446 (42) 1 325 (50) 3 611 (44) 3 827 (45) 
Adult 2 703 (26) 282 (11) 2 033 (25) 2 105 (25) 
Life span 3 263 (31) 1 019 (39) 2 551 (31) 2 549 (30) 
Sickle cell type     
HbSS 6 782 (65) 1 764 (67) 5 473 (67) 5 530 (65) 
HbS/β0 251 (2) 68 (3) 203 (2) 212 (2) 
HbSC 2 602 (25) 625 (24) 1 954 (24) 2 105 (25) 
HbS β+ 669 (6) 146 (5) 506 (6) 550 (6) 
Other type 108 (1) 23 (1) 92 (1) 84 (1) 

or Create an Account

Close Modal
Close Modal